Improved Outcome Following Busulfan-Based Conditioning in Children with Functional Neutrophil Disorders Undergoing Hematopoietic Stem Cell Transplant from HLA-Matched Donors
Journal of Clinical Immunology · 2023
DOI: 10.1007/s10875-023-01535-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Immunology, 2023. Verfasst von Elad Jacoby und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Hematology, Oncology and BMT, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel. elad.jaco…. Hauptthemen laut MEDLINE: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation, Granulomatous Disease, Chronic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 21 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Hematopoietic stem-cell transplantation (HSCT) is the only curative treatment for chronic granulomatous disease (CGD) and leukocyte-adhesion deficiency (LAD), but both diseases have high rates of graft failure in transplant and patients with these diseases are often referred to HSCT with significant comorbidity. The intensity of the conditioning regimen should be balanced between the need to ensure durable engraftment and to minimize toxicity when transplanting young children with infections and organ damage. We report on 26 children transplanted at our institution with CGD and LAD over 24 years. We found a higher incidence of graft failure in patients receiving treosulfan based conditioning for their first transplant. There was no effect of conditioning regimen on overall survival, as all 8 patients that proceeded to a second busulfan-based HSCT were salvaged. We recommend giving patients with CGD and LAD fully myeloablative conditioning with either a busulfan-based regimen or the combination of treosulfan, fludarabine, and thiotepa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Pediatric Hematology, Oncology and BMT, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel. elad.jacoby@sheba.gov.il.
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. elad.jacoby@sheba.gov.il.
- Division of Pediatric Hematology, Oncology and BMT, The Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
- Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Pediatric Department A and the Immunology Service, Jeffrey Modell Foundation Center, The Edmond And Lily Safra Children's Hospital, Sheba Medical Center, Ramat Gan, Israel.
Zitieren
APA
Jacoby, E., Adam, E., Hutt, D., Somech, R., Malkiel, S., Toren, A., & Bielorai, B. (2023). Improved Outcome Following Busulfan-Based Conditioning in Children with Functional Neutrophil Disorders Undergoing Hematopoietic Stem Cell Transplant from HLA-Matched Donors. Journal of Clinical Immunology. https://doi.org/10.1007/s10875-023-01535-2
Vancouver
Jacoby E, Adam E, Hutt D, Somech R, Malkiel S, Toren A, et al. Improved Outcome Following Busulfan-Based Conditioning in Children with Functional Neutrophil Disorders Undergoing Hematopoietic Stem Cell Transplant from HLA-Matched Donors. Journal of Clinical Immunology. 2023. doi:10.1007/s10875-023-01535-2
BibTeX
@article{Jacoby2023,
author = {Jacoby, Elad and Adam, Etai and Hutt, Daphna and Somech, Raz and Malkiel, Sarah and Toren, Amos and Bielorai, Bella},
title = {Improved Outcome Following Busulfan-Based Conditioning in Children with Functional Neutrophil Disorders Undergoing Hematopoietic Stem Cell Transplant from HLA-Matched Donors},
journal = {Journal of Clinical Immunology},
year = {2023},
doi = {10.1007/s10875-023-01535-2}
}
EUVIMED